GSK Doubles Down on Vaccine Equity with $5M COiMMUNITY Commitment
Event summary
- $2M awarded to 16 non-profits in 2025 COiMMUNITY grants, expanding vaccine education and access across the US.
- GSK commits $3M for 2026 grants, scaling up from previous years' funding.
- Grantees include health advocacy groups targeting meningococcal disease awareness and behavioral science training for healthcare providers.
- COiMMUNITY Initiative launched in 2023, now totaling $5M in grants and real-time adult immunization data through Vaccine Track.
The big picture
GSK's expanded COiMMUNITY funding reflects growing corporate investment in vaccine equity, addressing systemic barriers to immunization. The initiative aligns with broader industry trends toward preventive healthcare and data-driven public health strategies. With $5M committed since 2023, GSK is positioning itself as a key player in bridging vaccination gaps through targeted nonprofit partnerships.
What we're watching
- Impact Measurement
- How GSK will track and report the effectiveness of COiMMUNITY grants in improving immunization rates.
- Scalability
- Whether the $3M 2026 commitment can sustainably address vaccination gaps across diverse US communities.
- Regulatory Alignment
- The pace at which GSK's data transparency efforts through Vaccine Track may influence public health policy.
Related topics